Impact of iron deficiency on congestion and postdischarge survival in patients recently hospitalised for decompensated heart failure: a multicentre, prospective, observational analysis of the FERIC-RO study
Patients hospitalised for WCHF and ID had more residual congestion, higher absolute values and significantly lower in-hospital change of NT-proBNP. A significant difference in survival between the two ID groups emerged within 90 days of hospital discharge.
Authors
- Dragoş Vinereanu (ORCID: https://orcid.org/0000-0002-9054-8779)
- Andrew P. Ambrosy (ORCID: https://orcid.org/0000-0002-4563-1071)
- Javed Butler (ORCID: https://orcid.org/0000-0001-7683-4720)
- Dana Pop
- G. Tatu Chitoiu
- Sean P. Collins (ORCID: https://orcid.org/0000-0002-2305-9836)
- Ovidiu Chioncel (ORCID: https://orcid.org/0000-0002-3197-3628)
- Cornelia Margineanu (ORCID: https://orcid.org/0009-0007-2751-7391)
- Crina Sinescu (ORCID: https://orcid.org/0000-0001-5933-8549)
- Laura Antohi
- P S Pang
- Daniel Lighezan (ORCID: https://orcid.org/0000-0002-5725-8753)
- D. Bartos
Institutions
- Regenstrief Institute (US)
- Kaiser Permanente (US)
- Carol Davila University of Medicine and Pharmacy (RO)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- University of Mississippi Medical Center (US)
- West University of Timişoara (RO)
- Institutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu" (RO)
- Spitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara (RO)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Emergency University (US)
- VA Tennessee Valley Healthcare System (US)
- Geriatric Research Education and Clinical Center (US)
- Baylor Medical Center at Garland (US)
- Kaiser Permanente San Francisco Medical Center (US)
- Institute e-Austria Timisoara (RO)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Open Heart
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/openhrt-2024-002851
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novartis
- Vifor Pharma
- Servier
- Roche Diagnostics